Embryo Implantation ex vivo technology

About Serabiotics

Serabiotics is a Madrid-based biotech spin-off from Caltech, founded in 2015, that leverages its proprietary platform for isolating components from human plasma to create advanced tools for cell biology and assisted reproduction. The company's primary focus is on non-therapeutic applications, including developing embryo culture supplements, cell culture supplements, and specialized in vitro assays. It operates as a B2B developer and supplier, collaborating with pharmaceutical companies and research institutions to enhance embryo development, implantation research, and cell culture expansion. Serabiotics is positioned in the high-growth markets of IVF and cell therapy, offering enabling technologies rather than direct therapeutics.